Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

39
43 Of 101 S&P 500 Stocks Show 'Safer' Dividends Yielding 3% To 5.55% For July

2018-07-13 seekingalpha
43 of 101 S&P 500 Index top-yield dividend stocks were labeled as "safer" for dividends because they showed positive 1-year returns and free cash-flow yields greater than their dividend yields as of 7/9/18.
DLR.PRH DLR.PRG HCN PM DLR.PRJ PFG DLR.PRI WELL.PRI O.PRF MET STX OPRF PRU VZA IP CUKPF CCL WELL ABBV VTR PRU F INPAP PFK O CCL HCN.PRJ CUK HCN.PRI SPG.PRJ PRH CVX VZ VTRB SPG ABBV DLR QCOM DLR.PRC DLR.PRF PJH IVZ

4
Financials And Real Estate Dashboard - Update

2018-07-06 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages.
KIM.PRI PSA.PRA HCN PSA.PRB AIZ WELL.PRI PSA.A KIM.PRM KIM.PRL KIM.PRK KIM.PRJ WELL PSAXZ PSA.PRG PSA.PRE KIM PSA.PRF PSA.PRC PSA.PRD VTR PSA.PRY PSA.PRZ PSA.PRW HCN.PRJ PSA.PRX PSA.PRU PSA.PRV HCN.PRI PSA PSA.PRS PSA.PRT VTRB

43
4 High Dividend Stocks in the S&P 500 to Buy for Income

2018-07-03 investorplace
In a world of low interest rates, investors look for yield wherever they can find it. One common choice has become high-dividend stocks. In the previous century, dividends did not compare well to bank interest rates. However, as interest rates fell in this century, many decided the equity risk of stocks was worth the higher yields that dividend stocks pay today.
KIM.PRI HCN SCG TWX WELL.PRI CTL HCN.PRJ LB KIM.PRM TWC KIM.PRL HCN.PRI KIM.PRK KIM.PRJ AMZN T SCU WELL KIM

93
July 2018 Stock Considerations

2018-07-02 seekingalpha
Here we are with another installment of my "stock considerations" for the upcoming month. With the first week of trading upon us in July, it is time, once again, to lay out a plan for my potential stock pick(s) for the month. As many of you already know, I make sure to purchase at least one stock every single month, no matter where we are in a business or macroeconomic cycle. The goal of every long-term dividend growth investor is to remain consistent with their buys and try not to attempt to time the market and wait for the "best" possible time to invest.
SOJA HCN PM GIS HCP WELL.PRI LTC SBRA WELL CAH ED JCI SBRAP VTR SO GE GEC D HCN.PRJ KMB HCN.PRI PEP KHC GNE SBUX CLX

31
Welltower in Restructuring Mood, Pares Brookdale Portfolio

2018-06-28 zacks
Welltower Inc. (WELL - Free Report) has entered into a definitive agreement with its lessee and joint-venture (JV) partner — Brookdale Senior Living Inc. (BKD - Free Report) — for the comprehensive restructuring of the triple-net lease obligations on 63 communities of the latter. This move will significantly cut short Welltower’s association with Brookdale, as well as offer the former higher flexibility to form new JVs with preeminent senior housing operators.
HCN ABR WELL.PRI BKD CXP HCN.PRJ EXR HCN.PRI ABRN ABRN.CL WELL ABR.PRB ABR.PRC ABR.PRA

0
HCN / Welltower Inc. 8-K (Current Report)

2018-06-21 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HCN

8
Physicians Realty Trust: Healthcare REIT With 24.3% Discount

2018-05-28 seekingalpha
Physicians Realty Trust conveyed a very strong and consistent performance amid the first three months of 2018.
VTR HCN DOC WELL.PRI HCP WELL VTRB HCN.PRJ HCN.PRI

0
Why Is Welltower (WELL) Up 12.5% Since Its Last Earnings Report?

2018-05-28 zacks
A month has gone by since the last earnings report for Welltower Inc. (WELL - Free Report) . Shares have added about 12.5% in that time frame.
DUKH XEL HCN WELL.PRI WELL DUK HCN.PRJ HCN.PRI

2
HCN / Welltower Inc. 8-K (Current Report)

2018-05-21 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HCN

114
4 High Dividend Stocks in the S&P 500 to Buy for Income

2018-05-21 investorplace
In a world of low interest rates, investors look for yield wherever they can find it. One common choice has become high dividend stocks. In the previous century, dividends did not compare well to bank interest rates. However, as interest rates fell in this century, many decided the equity risk of stocks were worth the higher yields that dividend stocks pay today.
KIM.PRI HCN SCG TWX WELL.PRI CTL HCN.PRJ LB KIM.PRM TWC KIM.PRL HCN.PRI KIM.PRK KIM.PRJ AMZN T SCU WELL KIM

68
Welltower upgraded to outperform from market perform at Raymond James

2018-05-21 marketwatch
The real estate investment trust (REIT) sector is the best performer of the S&P 500's 11 sectors, as the high-yielding stocks continue to benefit from the recent decline in Treasury yields. The SPDR Real Estate Select Sector ETF rallied 2.1%, with all 33 equity components gaining ground. The REIT sector tracker has a payout yield of 3.39%, compared with the implied dividend yield of the S&P 500 of 1.
REG MGM HCN FB PM GEO WELL.PRI EPD KALA WELL JCAP.PRB LMBS VTR REG.PRG REG.PRF DOC ZTO HCN.PRJ L HCN.PRI HRL FTSM FDIV SPG.PRJ VTRB JCAP NVS SPG OHI

1
HCN / Welltower Inc. 424B5 (Prospectus)

2018-05-18 sec.gov
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-225004
HCN

0
HCN / Welltower Inc. 424B5 (Prospectus)

2018-05-18 sec.gov
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-225004
HCN

0
HCN / Welltower Inc. FORM 8-K (Current Report)

2018-05-18 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HCN

97
7 Great Ways to Move Into Real Estate Investing

2018-05-18 investorplace
Real estate is an attractive investment category — and also a risky one. Owning physical real estate can provide attractive returns, but a lot can go wrong: tenants can leave in the middle of the night, pipes can burst and markets can change without warning.
KBWY PSA.PRA HCN ROOF PSA.PRB AMT.PRB AMT.PRA WELL.PRI PSA.A SBRA AMT EQR WELL PSAXZ PSA.PRG GGP PSA.PRE MAC PSA.PRF AVB PSA.PRC PSA.PRD VTR PSA.PRY PSA.PRZ PSA.PRW HCN.PRJ PSA.PRX PSA.PRU PSA.PRV HCN.PRI PSA PSA.PRS PSA.PRT SPG.PRJ GNL SPG GNL.PRA WPG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 95040Q104